Godrej Agrovet announced its unaudited financial results for Q3FY26 ended December 31, 2025, delivering consolidated net profit of ₹109.73 crore and revenue from operations of ₹2,718.32 crore. The company reported EBITDA of ₹2.42 billion compared to ₹2.34 billion in the corresponding quarter last year, though EBITDA margin compressed to 8.9% from 9.54% year-on-year. The Board of Directors approved these results at their meeting held on February 3, 2026, pursuant to Regulations 30, 33 and 52(4) of SEBI Listing Regulations.

Financial Performance Overview

The company's Q3FY26 consolidated performance demonstrates steady growth in revenue while maintaining stable profitability. Total income reached ₹2,736.66 crore for the quarter, with total expenses managed at ₹2,567.33 crore, resulting in profit before tax of ₹146.47 crore.

Segment-wise Business Performance

The company's diversified business model showed varied performance across segments. Animal Feed business generated revenue of ₹1,298.39 crore, while Vegetable Oil segment contributed ₹626.91 crore. The Crop Protection business recorded ₹259.88 crore in revenue, with Dairy operations adding ₹379.83 crore to the overall performance.

Nine Months Performance

For the nine months ended December 31, 2025, the company achieved consolidated revenue from operations of ₹7,900.03 crore compared to ₹7,249.13 crore in the corresponding period last year. Net profit for the nine-month period stood at ₹342.90 crore versus ₹337.27 crore in the previous year.

Operational Highlights and Regulatory Compliance

The company maintained strong operational metrics with a current ratio of 0.79 and debt equity ratio of 0.81. Net worth increased to ₹2,057.68 crore, reflecting the company's solid financial foundation. The results include exceptional items of ₹30.44 crore related to statutory impact of new Labour Codes, primarily arising from changes in wage definition affecting gratuity and leave encashment benefits. The financial results received unmodified opinion from statutory auditors BSR & Co. LLP.

Godrej Agrovet Limited has formally notified stock exchanges about an upcoming conference call with investors and analysts to discuss its Q3FY26 and 9MFY26 financial results. The company filed the intimation with BSE Limited and National Stock Exchange of India Limited on January 16, 2026.

Conference Call Details

The earnings call is scheduled for Wednesday, February 4, 2026, at 3:30 PM IST. Equirus Securities will host the conference call on behalf of Godrej Agrovet Limited following the announcement of financial results for the quarter and nine months ended December 31, 2025.

Management Participation

The conference call will feature senior management representatives who will participate in the earnings discussion and Q&A session:

• Mr. Nadir Godrej – Chairman
• Mr. Sunil Kataria – Chief Executive Officer & Managing Director
• Mr. S. Varadaraj – Chief Financial Officer
• Mr. Burjis Godrej – Managing Director (Astec LifeSciences)
• Mr. Arijit Mukherjee – Chief Operating Officer (Astec LifeSciences)

Call Access Information

The company has provided multiple dial-in options for participants across different regions. Domestic participants can use the primary number +91 22 6280 1224 or secondary number +91 22 7115 8125.

Session Format

The conference call will commence with a brief management discussion on the Q3FY26 and 9MFY26 earnings performance. This will be followed by an interactive Question & Answer session where analysts and investors can engage directly with the management team.

Participants are encouraged to pre-register to avoid wait time. For additional information, participants can contact Siddharth Gadekar, Associate Director – Chemicals, Metals & Mining at Equirus Securities, or Shivansh Singh, Associate – Chemicals, Metals and Mining at the same firm.

The notification was signed by Vivek Raizada, Head – Legal & Company Secretary & Compliance Officer, and the information is also available on the company's website at www.godrejagrovet.com .